What explains GUTS' fluctuating other items?
5/9/2025 03:28pm
The stock price of GUTS has experienced a significant increase of 24.41% on May 2, 2025. Fractyl Health, the company behind GUTS, has been busy preparing for two investor events and presenting preclinical data on its Rejuva gene therapy platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting. These factors, combined with the broader market trends, provide a comprehensive explanation for the observed fluctuations in the stock price of GUTS.
|code|Ticker|Name|Date|Percentage Change|market_code|
|---|---|---|---|---|---|
|GUTS|GUTS.O|Fractyl Health|20250508|9.2715|185|